164 related articles for article (PubMed ID: 17476473)
41. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
42. TGFbeta1 signaling via alphaVbeta6 integrin.
Kracklauer MP; Schmidt C; Sclabas GM
Mol Cancer; 2003 Aug; 2():28. PubMed ID: 12935295
[TBL] [Abstract][Full Text] [Related]
43. Perillyl alcohol causes G1 arrest through p15(INK4b) and p21(WAF1/Cip1) induction.
Koyama M; Sowa Y; Hitomi T; Iizumi Y; Watanabe M; Taniguchi T; Ichikawa M; Sakai T
Oncol Rep; 2013 Feb; 29(2):779-84. PubMed ID: 23233050
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.
Chan DW; Liu VW; To RM; Chiu PM; Lee WY; Yao KM; Cheung AN; Ngan HY
Br J Cancer; 2009 Oct; 101(8):1433-43. PubMed ID: 19755996
[TBL] [Abstract][Full Text] [Related]
45. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
[TBL] [Abstract][Full Text] [Related]
46. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Giehl K; Seidel B; Gierschik P; Adler G; Menke A
Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
[TBL] [Abstract][Full Text] [Related]
47. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
[TBL] [Abstract][Full Text] [Related]
48. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
49. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
De Bosscher K; Hill CS; Nicolás FJ
Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
[TBL] [Abstract][Full Text] [Related]
50. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
51. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.
Datto MB; Hu PP; Kowalik TF; Yingling J; Wang XF
Mol Cell Biol; 1997 Apr; 17(4):2030-7. PubMed ID: 9121451
[TBL] [Abstract][Full Text] [Related]
52. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.
Niu B; Liu J; Lv B; Lin J; Li X; Wu C; Jiang X; Zeng Z; Zhang XK; Zhou H
Nat Commun; 2021 May; 12(1):2809. PubMed ID: 33990575
[TBL] [Abstract][Full Text] [Related]
53. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.
Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME
J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
Lin LC; Hsu SL; Wu CL; Liu WC; Hsueh CM
Cell Signal; 2011 Oct; 23(10):1640-50. PubMed ID: 21664967
[TBL] [Abstract][Full Text] [Related]
55. GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.
Dong XM; Yin RH; Yang Y; Feng ZW; Ning HM; Dong L; Zheng WW; Tang LJ; Wang J; Jia YX; Jiang YN; Liu ED; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
Cell Signal; 2014 May; 26(5):1089-97. PubMed ID: 24509415
[TBL] [Abstract][Full Text] [Related]
56. Identification of
Liu YT; Xu L; Bennett L; Hooks JC; Liu J; Zhou Q; Liem P; Zheng Y; Skapek SX
Mol Cancer Res; 2019 Sep; 17(9):1854-1866. PubMed ID: 31189690
[TBL] [Abstract][Full Text] [Related]
57. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
Yang L; Ostrowski J; Reczek P; Brown P
Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
[TBL] [Abstract][Full Text] [Related]
58. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
[TBL] [Abstract][Full Text] [Related]
59. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
Giannouli CC; Kletsas D
Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
[TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
